REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bioengineering.Pl Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Bioengineering.Pl Sp. z o.o. Profile Updated: July 06, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

BioEngineering.pl is an interdisciplinary team of engineers specializing in medical, bio, and cyber technologies. The company supports the automation of the medical and pharmaceutical industry, creates tools and solutions for modern medicine using advanced automation and robotics, and consults on medical projects. BioEngineering.pl operates in the environment of strong magnetical fields and does not limit its activities to bioengineering projects.

Headquarters
Radzikow 28
Radzikow; Dolnoslaskie; Postal Code: 58-210

Contact Details: Purchase the Bioengineering.Pl Sp. z o.o. report to view the information.

Website: http://www.bioengineering.pl

Basic Information
Total Employees:
Purchase the Bioengineering.Pl Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Bioengineering.Pl Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Bioengineering.Pl Sp. z o.o. report to view the information.
Incorporation Date:
June 28, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
59.18%
Purchase this report to view the information.
20.41%
Company Performance
Financial values in the chart are available after Bioengineering.Pl Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-58.24%▼
Total operating revenue
-39.58%▼
Operating profit (EBIT)
-42.2%▼
EBITDA
-38.02%▼
Net Profit (Loss) for the Period
-42.2%▼
Total assets
21.94%▲
Total equity
22.88%▲
Operating Profit Margin (ROS)
77.01%▲
Net Profit Margin
77.01%▲
Return on Equity (ROE)
-20.96%▼
Debt to Equity Ratio
5.62%▲
Quick Ratio
0.59%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo